Literature DB >> 2302466

Cell kinetics after high dose cytosine arabinoside in patients with acute myelocytic leukemia.

L P Colly1, W G Peters, M W Arentsen-Honders, R Willemze.   

Abstract

In this study 10 patients with acute myelocytic leukemia (AML) each received a rapid intravenous injection of high dose cytosine arabinoside (HD Ara-C; 1 g/m2). Bone marrow aspirates were obtained before and after Ara-C administration to determine the percentage of cells in S-phase measured by flow cytometry. In 5 out of 10 cases synchronization of the leukemic cells in S-phase of the cell cycle was observed. However, the time of maximum synchronization turned out to be difficult to predict. Therefore, the strong correlation between percentage of cells in S-phase at diagnosis and the time of maximal accumulation of S-phase cells after Ara-C administration, as observed by others in childhood AML, could not be confirmed for adult AML patients. Although synchronization of AML cells after in vivo Ara-C administration could be demonstrated in at least half of the patients, the practical consequences are such that clinical application was hampered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302466     DOI: 10.1007/bf01720511

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  Percentage of S-phase cells in bone marrow aspirates, biopsy specimens and bone marrow aspirates corrected for blood dilution from patients with acute leukemia.

Authors:  L P Colly; W G Peters; J Hermans; W Arentsen-Honders; R Willemze
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

Review 2.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

3.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin.

Authors:  D Roos; J A Loos
Journal:  Biochim Biophys Acta       Date:  1970-12-29

4.  A simplified method of DNA distribution analysis.

Authors:  P N Dean
Journal:  Cell Tissue Kinet       Date:  1980-05

5.  Cytokinetic changes after cytosine arabinoside in acute non-lymphocyte leukemia.

Authors:  A M Drenthe-Schonk; R S Holdrinet; J van Egmond; J M Wessels; C Haanen
Journal:  Leuk Res       Date:  1981       Impact factor: 3.156

6.  Effect of adriamycin and analogs on the nuclear fluorescence of propidium iodide-stained cells.

Authors:  A Krishan; R N Ganapathi; M Israel
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

7.  Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.

Authors:  L P Colly; W G Peters; R Willemze
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Enhanced tumor load reduction after chemotherapy induced recruitment and synchronization in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.

Authors:  L P Colly; D W van Bekkum; A Hagenbeek
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

9.  Cell kinetic studies after high dose Ara-C and adriamycin treatment in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.

Authors:  L P Colly; D W van Bekkum; A Hagenbeek
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

10.  Synchronization and recruitment in acute leukemia.

Authors:  B C Lampkin; T Nagao; A M Mauer
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  1 in total

1.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.